257 related articles for article (PubMed ID: 6134598)
1. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
Knight A; Adams DD
Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
[TBL] [Abstract][Full Text] [Related]
2. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
[TBL] [Abstract][Full Text] [Related]
3. [LATS and other antibodies against the TSH receptor].
Rodríguez Zapata MM
Med Clin (Barc); 1983 Feb; 80(4):177-81. PubMed ID: 6134881
[No Abstract] [Full Text] [Related]
4. Anti-tubulin antibodies in autoimmune thyroid disorders.
Rousset B; Bernier-Valentin F; Poncet C; Orgiazzi J; Madec AM; Monier JC; Mornex R
Clin Exp Immunol; 1983 May; 52(2):325-32. PubMed ID: 6688044
[TBL] [Abstract][Full Text] [Related]
5. Thyroid-stimulating autoantibodies usually contain only lambda-light chains: evidence for the "forbidden clone" theory.
Knight J; Laing P; Knight A; Adams D; Ling N
J Clin Endocrinol Metab; 1986 Feb; 62(2):342-7. PubMed ID: 2867105
[TBL] [Abstract][Full Text] [Related]
6. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
Földes J; Takó J; Bános C; Gesztesi E; Varga I
Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
[No Abstract] [Full Text] [Related]
7. LATS and Graves' disease.
Soloman DH; Chopra IJ
Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
[No Abstract] [Full Text] [Related]
8. Adsorption of thyroid-stimulating antibody (TSAb) of Graves' disease by homologous and heterologous thyroid tissue.
Zakarija M; McKenzie JM
J Clin Endocrinol Metab; 1978 Oct; 47(4):906-8. PubMed ID: 95627
[TBL] [Abstract][Full Text] [Related]
9. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.
Hopf U; Fiek T; Grün R; Zuschneid W
J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440
[TBL] [Abstract][Full Text] [Related]
11. Detectability of antibodies directed against different thyroid structures by indirect immunofluorescence, with Graves' patients' sera. A prospective study.
Szabo J; Forizs E; Bako G; Mezösi E; Leövey A
Radiobiol Radiother (Berl); 1987; 28(5):590-5. PubMed ID: 2894708
[No Abstract] [Full Text] [Related]
12. Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease.
Ohkura T; Taniguchi S; Yamada K; Nishio N; Okamura T; Yoshida A; Kamijou K; Fukata S; Kuma K; Inoue Y; Hisatome I; Senju S; Nishimura Y; Shigemasa C
Biochem Biophys Res Commun; 2004 Aug; 321(2):432-40. PubMed ID: 15358194
[TBL] [Abstract][Full Text] [Related]
13. [Effect of iodinization on some properties of LATS and antithyroid antibodies].
Romaldini JH; Pinchera A; Fenzi GF; Grasso L; Raccis E; Mariotti S; Baschieri L
Folia Endocrinol; 1974 Feb; 27(1):110-6. PubMed ID: 4549507
[No Abstract] [Full Text] [Related]
14. Zoological specificity of human thyroid-stimulating antibody.
Zakarija M; McKenzie JM
J Clin Endocrinol Metab; 1978 Aug; 47(2):249-54. PubMed ID: 45462
[TBL] [Abstract][Full Text] [Related]
15. Comparison of thyroid antigens by the experimental production of precipitating antibodies to human thyroid fractions and the identification of an antibody which competes with long-acting thyroid stimulator (LATS) for thyroid binding.
von Westarp C; Knox AJ; Row VV; Volpé R
Acta Endocrinol (Copenh); 1977 Apr; 84(4):759-67. PubMed ID: 576759
[TBL] [Abstract][Full Text] [Related]
16. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
17. [TSH-receptor-bound antithyroid antibody and the etiology of Basedow's disease].
Shishiba Y
Nihon Rinsho; 1983; 41(4):801-7. PubMed ID: 6310180
[No Abstract] [Full Text] [Related]
18. LATS protector, the human thyroid stimulator.
Adams DD
N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
[No Abstract] [Full Text] [Related]
19. LATS-protector activity in thyrotoxicosis measured by thyroidal intracellular colloid droplet formation.
Shishiba Y; Miyachi Y; Takaishi M; Ozawa Y
J Clin Endocrinol Metab; 1978 May; 46(5):841-8. PubMed ID: 262769
[TBL] [Abstract][Full Text] [Related]
20. The thyroid-stimulating antibody of Graves' disease: evidence for restricted heterogeneity.
Zakarija M
Horm Res; 1980; 13(1):1-15. PubMed ID: 6777285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
